Replication Termination Factor 2, often abbreviated as RTF2, is a protein involved in the process of DNA replication, particularly in the termination phase. It plays a pivotal role in ensuring that the replication of the genome is accurately completed without stalling or errors, which is vital for maintaining genomic stability and preventing the accumulation of mutations that could lead to diseases such as cancer.RTF2 is characterized by its ability to bind to specific DNA sequences and structures that arise during the termination of DNA replication. Its function is associated with the recognition and resolution of converging replication forks, which are junctions where two opposing DNA replication complexes meet at the end of replicative events. RTF2 helps in disentangling these replication complexes, ensuring that the replication machinery can properly disassemble once the entire genome has been duplicated.
The importance of RTF2 is underscored by its conservation across various species, indicating that its role in replication termination is critical for cellular division and the propagation of genetic information. In eukaryotic cells, RTF2 is part of a larger terminus site-binding protein complex that recognizes termination sites and aids in the cessation of replication.While the exact mechanisms of RTF2's action are still under investigation, it is understood that the protein interacts with other replication factors and possibly with the replication machinery itself to signal the end of the replication process. This interaction ensures that the replication forks are not only stopped correctly but also that the newly synthesized DNA strands are properly processed and that any remaining replication proteins are removed from the DNA.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin is a DNA polymerase inhibitor, affecting DNA replication and potentially impacting RTF2-related processes. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits topoisomerase I, crucial for DNA replication and cell division, potentially affecting RTF2 function. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide is a topoisomerase II inhibitor, affecting DNA replication and cell cycle progression, which may intersect with RTF2 activities. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, leading to decreased deoxyribonucleotide pools and affecting DNA replication. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Gemcitabine is a nucleoside analog that inhibits DNA synthesis, potentially impacting replication processes involving RTF2. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib is a CDK4/6 inhibitor, affecting cell cycle progression and potentially influencing RTF2 function in replication. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
Ribociclib, another CDK4/6 inhibitor, regulates cell cycle progression, which could indirectly affect RTF2. | ||||||
Abemaciclib | 1231929-97-7 | sc-507342 | 10 mg | $110.00 | ||
Abemaciclib selectively inhibits CDK4/6, impacting cell cycle control and possibly RTF2's role in replication. | ||||||
Ceralasertib | 1352226-88-0 | sc-507439 | 10 mg | $573.00 | ||
AZD6738 is an ATR kinase inhibitor, involved in DNA damage response and replication stress, potentially relevant to RTF2. | ||||||
PF 477736 | 952021-60-2 | sc-362781 sc-362781A | 5 mg 25 mg | $115.00 $431.00 | ||
PF-477736 inhibits CHK1, a kinase in the DNA damage response pathway, which may intersect with RTF2 activities. | ||||||